Yuan Shuo, Li You, Li Jiao, Xue Jia-Chen, Wang Qi, Hou Xiao-Ting, Meng Huan, Nan Ji-Xing, Zhang Qing-Gao
Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, College of Pharmacy, Yanbian University, Yanji, China.
Chronic Disease Research Center, Medical College, Dalian University, Dalian, China.
Front Pharmacol. 2022 Jul 7;13:892790. doi: 10.3389/fphar.2022.892790. eCollection 2022.
Inflammatory bowel disease (IBD) is a rare, recurrent, and intractable inflammation obstruction of the stomach tract, usually accompanied by inflammation of cell proliferation and inflammation of the colon and carries a particular cause of inflammation. The clinical use of drugs in western countries affects IBD treatment, but various adverse effects and high prices limit their application. For these reasons, Traditional Chinese Medicine (TCM) is more advantageous in treating IBD. This paper reviews the mechanism and research status of TCM and natural products in IBD treatment by analyzing the relevant literature to provide a scientific and theoretical basis for IBD treatment.
炎症性肠病(IBD)是一种罕见的、复发性的、难治性的胃肠道炎症性梗阻,通常伴有细胞增殖炎症和结肠炎症,并具有特定的炎症原因。西方国家药物的临床应用影响IBD治疗,但各种不良反应和高昂价格限制了它们的应用。基于这些原因,中医药在治疗IBD方面更具优势。本文通过分析相关文献,综述了中医药及天然产物在IBD治疗中的作用机制和研究现状,为IBD治疗提供科学的理论依据。